Buy Rating Affirmed for 2seventy Bio on Strong Growth Prospects and Financial Stability

TipRanksMay 10 13:33

2seventy bio | 10-Q: Quarterly report

Futu NewsMay 10 04:10 · Announcements

2seventy Bio Is Maintained at Buy by Canaccord Genuity

2seventy Bio Is Maintained at Buy by Canaccord Genuity

Dow JonesMay 10 03:18

Canadian Investment Banking Group: Maintaining the 2seventy bio (TSVT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $11.00.

Canadian Investment Banking Group: Maintaining the 2seventy bio (TSVT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $11.00.

Zhitong FinanceMay 10 03:10

Canaccord Genuity Maintains Buy on 2seventy Bio, Lowers Price Target to $11

Canaccord Genuity analyst John Newman maintains 2seventy bio (NASDAQ:TSVT) with a Buy and lowers the price target from $12 to $11.

BenzingaMay 10 03:08

2seventy Bio Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 148.31% Canaccord Genuity $12 → $11 Maintains Buy 04/08/2024 170.88% Citigroup $9 → $12 Maintai

BenzingaMay 10 03:06